Directory
>
Jeff Moehlenkamp
Jeff Moehlenkamp
Post-doctoral research fellow | Gilgamesh Pharma
Indiana, Newburgh, United States
Jeff Moehlenkamp
Summary
Jeff Moehlenkamp is a seasoned scientific leader with over 24 years of experience in nonclinical toxicology and drug development. Currently serving as the Senior Director and Head of Toxicology at Karuna Therapeutics, he has a rich background in operations and research within the pharmaceutical industry. Jeff's career includes significant roles at Bristol Myers Squibb, where he advanced through various positions, showcasing his expertise in toxicology operations. He holds a PhD in Pharmacology and Toxicology from the University of Kansas Medical Center and a B.S. in Biology from Butler University. His commitment to innovation in drug safety is complemented by his leadership in diverse teams and projects. Jeff is known for his strategic approach to toxicology, which integrates scientific rigor with business acumen. Outside of work, he enjoys engaging in community initiatives that promote science education.
Jeff Moehlenkamp
Work Experience
VP, Head of Toxicology at
Gilgamesh Pharma
May 2025 - Present
Jeff Moehlenkamp
Education
Butler University, B.S., Biology
January 1989 - January 1993
University of Kansas Medical Center, PhD, Pharmacology / Toxicology
January 1994 - January 1999
Frequently Asked Questions about Jeff Moehlenkamp
What is Jeff Moehlenkamp email address?
Jeff Moehlenkamp's primary email address is ****************@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jeff Moehlenkamp work for?
Jeff Moehlenkamp is a Post-doctoral research fellow at Gilgamesh Pharma.
Where Jeff Moehlenkamp graduated from?
Jeff Moehlenkamp holds a degree in null from Butler University.
How can I directly contact Jeff Moehlenkamp?
To contact Jeff Moehlenkamp directly, you can use the email address ****************@bms.com. Complete contact information is available upon registration with Muraena.
Who is Jeff Moehlenkamp?
Jeff Moehlenkamp is a seasoned scientific leader with over 24 years of experience in nonclinical toxicology and drug development. Currently serving as the Senior Director and Head of Toxicology at Karuna Therapeutics, he has a rich background in operations and research within the pharmaceutical industry. Jeff's career includes significant roles at Bristol Myers Squibb, where he advanced through various positions, showcasing his expertise in toxicology operations. He holds a PhD in Pharmacology and Toxicology from the University of Kansas Medical Center and a B.S. in Biology from Butler University. His commitment to innovation in drug safety is complemented by his leadership in diverse teams and projects. Jeff is known for his strategic approach to toxicology, which integrates scientific rigor with business acumen. Outside of work, he enjoys engaging in community initiatives that promote science education.
Jeff`s contact details
****************@bms.com
************@karunatx.com
Colleagues
Scientist